Methylnaltrexone for Opioid-induced Constipation in Cancer Patients
NCT01004393
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Neoplasms
Constipation
Opioid-Related Disorders
Interventions
DRUG:
Methylnaltrexone bromide
Sponsor
University of Vermont